DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS (Q2035310)
Jump to navigation
Jump to search
Project Q2035310 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS |
Project Q2035310 in Italy |
Statements
183,393.18 Euro
0 references
366,786.35 Euro
0 references
50.0 percent
0 references
13 December 2016
0 references
6 July 2019
0 references
UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA
0 references
KAY SYSTEMS ITALIA SRL
0 references
LA RADIOTERAPIA MOLECOLARE, INDICATA IN MOLTE NEOPLASIE, IMPIEGA RADIONUCLIDI COME SORGENTI NON SIGILLATE (SPESSO RADIOFARMACI) PER RILASCIARE RADIAZIONI E DISTRUGGERE CELLULE NEOPLASTICHE. (Italian)
0 references
THE MOLECULAR RADIOTHERAPY, REFERRED TO IN MANY CANCERS, USES RADIONUCLIDES AS NON-SEALED SOURCES (OFTEN RADIOPHARMACEUTICALS) TO RELEASE RADIATION AND DESTROY NEOPLASTIC CELLS. (English)
0 references
LA RADIOTHÉRAPIE MOLÉCULAIRE, INDIQUÉE DANS DE NOMBREUX NÉOPLASMES, UTILISE LES RADIONUCLÉIDES COMME SOURCES NON SCELLÉES (SOUVENT RADIOPHARMACEUTIQUES) POUR LIBÉRER LE RAYONNEMENT ET DÉTRUIRE LES CELLULES NÉOPLASIQUES. (French)
16 December 2021
0 references
MOLECULAIRE RADIOTHERAPIE, GEÏNDICEERD IN VEEL NEOPLASMA’S, GEBRUIKT RADIONUCLIDEN ALS NIET-VERZEGELDE BRONNEN (VAAK RADIOFARMACEUTICA) OM STRALING VRIJ TE GEVEN EN NEOPLASTISCHE CELLEN TE VERNIETIGEN. (Dutch)
23 December 2021
0 references
MOLEKULARE STRAHLENTHERAPIE, DIE IN VIELEN NEOPLASMEN ANGEZEIGT WIRD, VERWENDET RADIONUKLIDE ALS NICHT VERSIEGELTE QUELLEN (OFT RADIOPHARMAZEUTIKA), UM STRAHLUNG FREIZUSETZEN UND NEOPLASTISCHE ZELLEN ZU ZERSTÖREN. (German)
24 December 2021
0 references
LA RADIOTERAPIA MOLECULAR, INDICADA EN MUCHAS NEOPLASIAS, UTILIZA RADIONUCLEIDOS COMO FUENTES NO SELLADAS (A MENUDO RADIOFÁRMACAS) PARA LIBERAR RADIACIÓN Y DESTRUIR CÉLULAS NEOPLÁSICAS. (Spanish)
25 January 2022
0 references
Identifiers
F87H18000440007
0 references